Full-Time

Veterinary Technician

Posted on 11/9/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Columbia, MO, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Associates or Bachelor’s degree with experience in clinical or research setting
  • Applicable state licensing for Veterinary technician (CVT/LVT/RVT); or high school diploma/GED with one year of relevant experience; Equivalent combination of experience may substitute for education
  • 6-12 months basic animal handling and/or basic medical/veterinary experience
  • Basic computer skills
  • Requires general reading, writing, and verbal communication skills
  • The ability to quickly understand and act on complex instructions delivered either verbally or in writing, and the ability to communicate with a wide variety of individuals in a professional, respectful, and clear manner
  • Requires the ability to accurately calculate doses
  • Possesses foundational skills in anesthetic monitoring and surgical preparation
  • Demonstrates mid-level proficiency in animal handling and procedural skills
  • Exhibits a basic understanding of general medical principles and practices
  • Basic animal handling
Responsibilities
  • Follow all Altasciences Standard Operating Procedures (SOPs) and is compliant with GLP, ALCOA+, USDA, and AAALAC
  • Participate in animal health duties, including examination/treatment of animals under the guidance of APC veterinarians and maintain animal health records
  • Performs routine quality control on all paperwork and performs computer entry and/or data retrieval as appropriate
  • Performs routine diagnostic/screening tests and veterinary procedures (such as body weights, body condition score (BCS), fecal examination, blood collection, dose administration, sample processing, and tissue collection)
  • Provides surgical support by preparing patients, medications, and equipment for surgery, and monitoring animals while under anesthesia. May assist in surgical procedures and/ or advanced diagnostic/treatment procedures
  • Perform general housekeeping duties such as surgical sanitation, study set-up, study clean-up, equipment maintenance and validation, and organization of vet spaces
  • Performs dose calculations for medications to be given based on initial orders from a veterinarian or as per SOP or Protocol and may be responsible for ordering substances from the pharmacy for planned procedures
  • Proficient in working with core animal species, ensuring the correct handling, restraint, and manipulation of sedated and non-sedated animals for essential procedures
  • Contributes to data collection, aiming to achieve high data quality
  • Assists Research Associates, Post-Life, and/or Labs and participates in weekend and evening rotations, as needed
Desired Qualifications
  • Working toward the AALAS Assistant Laboratory Animal Technician (ALAT) certification level or equivalent
  • State Veterinary Technician License is preferred

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE